<sup>125</sup>I籽源组织间照射在肿瘤治疗中的应用

岳麓; 程文英; 刘伟填

¹²⁵I籽源组织间照射在肿瘤治疗中的应用

岳麓 , 程文英 , 刘伟填

文章导航 > 国际放射医学核医学杂志 > 2001, 25 > 1: (23-26,41)

引用本文:

Citation:

¹²⁵I籽源组织间照射在肿瘤治疗中的应用

200032 上海, 复旦大学放射医学研究所

作者简介: 岳麓(1971-),男,山东济南人,复旦大学放射医学研究所(原上海医科大学放射医学研究所)第三研究室硕士研究生,主要从事实验肿瘤及放射敏感性的研究。;

中图分类号: R817.8

Implantation with ¹²⁵I seeds for the treatment of tumor

YUE Lu,

Institute of Radiation Medicine, FuDan University Shanghai, 200032, China
CLC number: R817.8

摘要: ¹²⁵I的生物物理学特征适用于组织间放疗。在国外,用¹²⁵I组织间照射治疗恶性肿瘤已有较广泛的应用,尤其是将¹²⁵I籽源植入作为一种独特的方法用于治疗前列腺癌已经相当成熟,但是在其他肿瘤的治疗方面还处于研究阶段。
- 近距离组织间照射 /
- ¹²⁵I /
- 肿瘤治疗
Abstract: Thc ¹²⁵I with special biological and physical characters is available to interstitial brachytherapy. The ¹²⁵I seeds implantation is widely used in treating malignant tumor abroad. Implantation with ¹²⁵I seeds is an important and effective method in the treatment of prostate cancer, but it is performed as pilot study in the treatment of other tumors.
- interstitial brachytherapy /
- iodine-125 /
- treatment of tumor
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Lazarescu GR,Battista JJ.Analysis of the radiobiolo-gy of Ytterbium-169 and Iodine-125 permanent brachytherapy implants[J].Phys Med Biol,1997,42:1727-1736.
[2]	Ling CC.Permanent implams using Au-198,Pd-103 and I-125:Radiobiological considerations based on the linear quadratic model[J].Int J Radiat Oncol Biol Phys,1992,23:81-87.
[3]	Kim JH,Hilaris BS.Iodinc-125 sourcc in interstitial tumor therapy[J].Radiology,1975,123:163-169.
[4]	Anderson LL,Kuan HM,Ding IY.Clinical dosimetry with I-125[A].In Gorge[ed].Modern interstitial and intracavitary radation cancer management[C].New York:Masson Publishing,1981.
[5]	Williamson JF.Physics of brachythcrapy[A].Perez CA,Brady LW[ed].Principles and practice of radia-tion oncology[C].Third Edition,Philadelphia:Lip-pincott-Raven,1997
[6]	Nath R,Anderson LL,Meli JA,et al.Code of prac-tice for brachytherapy physics:Report of the AAPM radation therpy committee task group NO.56[J].Med Phys,1997,24:1557-1579.
[7]	Wu A,Zwicker D,Sternick ES.Tumor dose specifi-cation of I-125 seed implants[J].Med Phys,1985,12:27-31.
[8]	Chen Y,Stanton RE,Holst RJ,et al.Treatment planning for prostate implant with loose seeds[J].Med Phys,1997,24:1141-1145.
[9]	Nath R,Anderson LL,Luxton G,et al.Dosimetry of interstitial brachtherapy sources:Recommendations of the AAPM radiation therapy committee task group NO.43[J].Med Phys,1995,22:209-233.
[10]	Williamson JF,Courscy BM,DeWerd LA,et al.Guidence to users of Nycomed Amersham and North American Scientific,Inc,I-125 interstitial sources:Dosimetry and calibration changes:Recommendations of the American Association of physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on low-energy[J].Med Phys,1999,26:570-573.
[11]	Kleinberg L,Wallner K,Roy J,et al.Treatment-re-lated srmptoms during the first year following transperineal I-125 prostate implanation[J].Int J Ra-diat Oncol Biol Phys,1994,28:985-990.
[12]	Wallner K,Roy J,Harrison L.Low risk of periopera-tive infection without pfophylactic for transperineal prostate brachytherapy[J].Int J Radiat Oncol Biol Phys,1996,36:681-683.
[13]	Beyer DC,Priestley JB.Biochemical disease-free sur-vival following I-125 prostate implantation[J].Int J Radiat Oncol Biol Phys,1997,37;559-563.
[14]	Ohorio M,Wheler TM,Scardino PT.The new American Joint Committee on Cancer and InternationalUnion Against Cancer TNM classification of prostate cancer[J].Cancer.1994,73:104-114.
[15]	Armstrong JG,Anderson LL,Harrison LB.Treat-ment of liver metastases from colorectal cancer with radioactive implants[J].Cancer,1994,73:1800-1804.
[16]	Martinez-Monge R,Nag S,Nieroda CA,et al.Io-dine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastic to the liver[J].Cancer,1999,85:1218-1225.
[17]	Chen A,Galloway M,Landreneau R,et al.Intraop-erative I-125 brachytherapy for high-risk stage I non-small cell lung carcinoma[J].Int J Radiat Oncol Biol Phys,1999,44:1057-1063.
[18]	Mittal BB,Nemcek AA,Sider L.Malignant tumors invading chest wall:Treatment with CT-directed im-plantation of radioactive seeds[J].Radiology,1993,186:901-903.
[19]	Schuricht AL,Spitz F,Barbct D,et al.Intraoperative radiotherapy in the combined modality management of pancreatic cancer[J].Am Surg,1998,1043-1049.

[1]	查金顺 . 恶性肿瘤术中组织间永久植入¹²⁵I粒子放疗. 国际放射医学核医学杂志, 2002, 26(5): 227-230.
[2]	法逸华 . ¹²⁵I粒子近距离照射在肿瘤治疗中的应用. 国际放射医学核医学杂志, 2003, 27(3): 115-117.
[3]	陈欢 , 郇福奎 , 门阔 , 戴建荣 , 任雯廷 . FLASH放疗技术对正常组织保护效应和肿瘤治疗效果的研究进展. 国际放射医学核医学杂志, 2024, 48(1): 52-59. doi: 10.3760/cma.j.cn121381-202307028-00384
[4]	阎尔坤 . ¹²⁵I密封籽源用于肿瘤治疗的动物实验初步研究. 国际放射医学核医学杂志, 2005, 29(4): 161-163.
[5]	胡瑞 , 林军 . ¹²⁵I粒子组织间植入近距离治疗恶性肿瘤. 国际放射医学核医学杂志, 2007, 31(6): 381-384.
[6]	董峰 , 谭建 , 周荫保 . ³²P在肿瘤治疗中的应用. 国际放射医学核医学杂志, 1998, 22(6): 255-258.
[7]	甄作武 , 林坚 , 杨锦钊 , 庞景灼 , 郑广钧 , 柴树德 . 影像引导下¹²⁵I粒子组织间植入近距离治疗肿瘤的应用进展. 国际放射医学核医学杂志, 2013, 37(2): 116-119. doi: 10.3760/cma.j.issn.1673-4114.2013.02.014
[8]	郑秀龙 . 1998:第10届国际肿瘤治疗化学修饰剂会议. 国际放射医学核医学杂志, 1999, 23(4): 171-174.
[9]	邹跃 , 周湘艳 . 端粒酶在肿瘤临床诊治中的应用前景. 国际放射医学核医学杂志, 2003, 27(3): 141-143.
[10]	陈洪雷 , 张可领 . 脑肿瘤的组织间近距离放射治疗. 国际放射医学核医学杂志, 2004, 28(1): 18-21.
[11]	张宏伟 , 李庆新 , 刘惠萍 , 晁栋 , 孟辉 . ¹²⁵I粒子永久性组织间植入治疗浅表恶性转移肿瘤. 国际放射医学核医学杂志, 2012, 36(3): 142-144. doi: 10.3760/cma.j.issn.1673-4114.2012.03.004